Form 4: Inari Medical CFO Kevin Strange Reports Beneficial Ownership Changes Following Stryker Merger

Following the merger of Inari Medical with Stryker Corporation, CFO Kevin Strange reports changes in his beneficial ownership of Inari Medical securities.

Summary

• Kevin T Strange, CFO of Inari Medical, Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• The filing is triggered by the merger between Inari Medical and Stryker Corporation, which became effective on February 19, 2025.
• As a result of the merger, each outstanding share of Inari Medical common stock was converted into the right to receive $80.00 in cash.
• Strange's restricted stock units (RSUs) and stock options were also cancelled and converted into the right to receive cash based on the merger consideration.
• Following the reported transactions, Strange's direct ownership of common stock and derivative securities is now zero.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The merger provides a clear exit strategy for shareholders at a defined price. The filing itself is a routine administrative step.

Positives

• The merger provides a cash payout of $80.00 per share for Inari Medical shareholders.

Future Outlook

The document does not contain any specific forward-looking statements beyond the completion of the merger.

Industry Context

The acquisition of Inari Medical by Stryker Corporation reflects a trend of consolidation in the medical device industry, where larger companies acquire smaller, innovative firms to expand their product portfolios and market reach.

Stakeholder Impact

• Shareholders receive $80.00 per share in cash.
• Employees of Inari Medical become part of Stryker Corporation.

Key Dates

Keywords

Merger, Inari Medical, Stryker Corporation, Form 4, Beneficial Ownership, Kevin Strange, CFO, Securities, RSUs, Stock Options